Advertisement

---

ATHERONOVA INC.

AtheroNova Announces Publication of Positive Pre-Clinical Results with AHRO-001 in the FASEB Journal

[2013-06-27] - Preclinical Study Conducted by David Geffen School of Medicine at UCLA Supports Clinical Development of Drug


AtheroNova Initiates Phase 1 Clinical Trial of AHRO-001, a Potential Treatment for Atherosclerosis

[2013-06-25] -


AtheroNova Announces Shipment of Phase 1 Drug Product

[2013-05-30] - Phase 1 Commencement in June


AtheroNova Announces Approval for Phase 1 by the Russian Ministry of Healthcare with Commencement of Human Trials Imminent

[2013-05-09] - Russian Licensing Partner Notified of Protocol Approval


Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers